Sebastian Kreuz
Executive Director / Investment Manager (BI Venture Fund)
Boehringer IngelheimIngelheim am Rhein, Rhineland-Palatinate, Germany
39 investmentsSebastian Kreuz is an Executive Director / Investment Manager (BI Venture Fund) at Boehringer Ingelheim based in Ingelheim am Rhein, Rhineland-Palatinate, Germany. Sebastian Kreuz has backed 39 companies, including Aignostics, T3 Pharmaceuticals and Dopavision. Investment focus areas include Health Care, Hospitals and Wellness.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Health Care
Hospitals
Wellness
Women Founded
Medical Testing
Chemical Engineering
Chemical
Life Science
Artificial Intelligence (AI)
Biotech
Software
Healthcare
Biotechnology
Market Research
Health Diagnostics
Beauty
Innovation Management
Medical
Therapeutics
Advanced Materials
Machine Learning
Personal Health
Pharmaceuticals
Portfolio Companies (39)
Showing 1–12 of 39
Page 1 of 4
Access Full Contact Information
Get Sebastian Kreuz's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
3-day free trial, cancel anytime
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.